Rituximab Antibody | AbD18423

//www.bio-rad-antibodies.com/rituximab-antibody-abd18423-hca186.html
Rituximab Antibody | AbD18423 gallery image 1

HCA186 PK assay. Human anti Rituximab (HCA186) was used as the coating antibody with Rituximab spiked in human serum as the antigen followed by detection with HRP conjugated anti-Rituximab antibody MCA2260

Enlarge
Rituximab Antibody | AbD18423 gallery image 2

HCA186 specificity ELISA using various antigens as coating reagents. Human anti Rituximab (HCA186) was used as the primary antibody followed by an anti His tag: HRP as a detection reagent

Enlarge
  • Rituximab Antibody | AbD18423 thumbnail image 1
  • Rituximab Antibody | AbD18423 thumbnail image 2
  • Human anti Rituximab
(Rated 0.0 out of 5 based on 0 customer reviews)
    Anti-rituximab antibody is a recombinant, neutralizing, high affinity anti-idiotypic antibody in monovalent Fab format; it is ideal for bioanalytical assays to measure levels of rituximab or biosimilars. It is recommended as capture antibody in PK bridging ELISA format with MCA2260P for detection.
    • Product Type
      Monoclonal Antibody
    • Clone
      AbD18423
    • Isotype
      HuCAL Fab monovalent
    1 Formats Available
      Product CodeApplicationsDatasheetMSDSPack SizeList PriceQuantity
      HCA186Edatasheet pdfdatasheet pdf0.1 mg
      HCA186
      Summary
      Secondary Antibodies
      Negative Isotype Controls
      Useful Reagents
      Positive Controls
      Histology Controls
      More Images
      References
      Reviews
      -
      • Human anti rituximab antibody, clone AbD18423 specifically recognises the idiotypic determinants expressed by the rituximab humanised monoclonal antibody, a therapeutic reagent directed against the human CD20 cell surface antigen.

        Human anti rituximab is an anti-idiotypic antibody that specifically recognises the rituximab humanised monoclonal antibody and can be used to measure the level of rituximab in serum from patients. This antibody may be used in a bridging ELISA in conjunction with MCA2260 .

        Additional antibodies recognising rituximab are also available from Bio-Rad.
      • Intended Use
      • Product Form
        A monovalent human recombinant Fab selected from the HuCAL® phage display library, expressed in E. coli. The antibody is tagged with a DYKDDDDK tag and a HIS-tag (HHHHHH) at the C-terminus of the antibody heavy chain. This antibody is supplied as a liquid.
      • Reconstitution
      • Preparation
        Metal chelate affinity chromatography.
      • Preservative Stabilisers
        0.01% Thiomersal
      • Immunogen
        Rituximab.
      • Purity
      • Affinity
        The intrinsic affinity of this antibody was measured as KD=0.13 nM by real time, label-free molecular interaction analysis on immobilized rituximab.
      • Approx. Protein Concentrations
        Total protein concentration 0.5 mg/ml.
      • Reagents In The Kit
      • Preparing The Antibody
      • Test Principle
      • Buffer Solution
        Phosphate buffered saline.
      • Storage
        Store at +4oC or at -20oC if preferred.
        Storage in frost-free freezers is not recommended.
        This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use.
      • Shelf Life
        12 months from date of despatch.
      • Acknowledgements
        Sold under license of U.S. Patents 6,300,064, 6,696,248, 6,708,484, 6,753,136, European Patent 0,859,841 and corresponding patents. This antibody was developed by Bio-Rad, a wholly owned subsidiary of Bio-Rad Laboratories Inc., Zeppelinstr. 4, 82178 Puchheim, Germany.
      • Licensed Use
        For in vitro research purposes and for commercial applications for the provision of in vitro testing services to support preclinical and clinical drug development. Any re-sale in any form or any other commercial application needs a written agreement with Bio-Rad.
      • Regulatory
        For research purposes only
      • This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information. For general protocol recommendations, please visit the antibody protocols page.

      • Application NameYesNoMin DilutionMax Dilution
        ELISA

      • Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
      • Technical Advice
        Recommended protocols and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual
      • Recommended Protocol
      • ELISA
        This product may be used as a capture antibody in a sandwich ELISA together with MCA2260P as the detection reagent. Protocol: PK bridging ELISA to measure free drug
      • Immunohistology
      • Histology Positive Control Tissue
      • Immunofluorescence
      • Western Blotting
      • Instructions For Use

      Additional Rituximab Antibody Formats

      Formats Clone Applications Sizes available
      Rituximab Antibody : Purified AbD18423 E 0.1 mg
      • Copyright © 2016 Bio-Rad

      Recommended Secondary Antibody

        Recommended Negative Isotype Control

          Useful Reagents

            DescriptionProduct CodePack SizeApplicationsList PriceQuantity
            Rat anti Rituximab:FITCMCA2260F0.1 mgF
            MCA2260F
            Human anti Rituximab:HRPHCA061P0.1 mgE
            HCA061P
            Human anti Rituximab:HRPHCA062P0.1 mgE
            HCA062P
            Rat anti Rituximab:HRPMCA2260P0.1 mgE
            MCA2260P
            Mouse anti Penta Histidine Tag:HRPMCA5995P125 µlE, WB
            MCA5995P
            Human anti RituximabHCA0610.1 mgE
            HCA061
            Human anti RituximabHCA0620.1 mgE
            HCA062
            Rat anti RituximabMCA22600.2 mgE, F
            MCA2260
            Human anti RituximabHCA061A50 µgE
            HCA061A
            Human anti RituximabHCA062A50 µgE
            HCA062A

            Recommended Positive Controls

              Histology Controls

                References

                Write your review

                You may also be interested in...

                You May Also Be Interested In...